CoverageForm 410-K10-Q8-K13D13G13F

G · Genpact Ltd - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · G

Income Statement

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Revenue$1.30B-$1.29B$1.25B$1.21B-$1.21B$1.18B$1.13B-
Cost of Revenue$824.40M-$821.60M$804.35M$785.93M-$779.51M$759.83M$734.76M-
Gross Profit$471.67M-$469.66M$450.07M$428.99M-$431.44M$416.38M$396.48M-
R&D----------
SG&A$270.34M-$262.11M$266.39M$241.08M-$243.31M$239.64M$235.03M-
Total Operating Expenses----------
D&A$17.73M---$16.89M---$17.28M-
Operating Income$198.58M-$191.64M$179.40M$183.70M-$181.65M$170.25M$159.99M-
Interest Expense----------
Income Tax$46.00M-$43.52M$44.02M$44.37M-$42.67M$40.43M$39.42M-
Net Income$147.99M-$145.83M$132.72M$130.85M-$132.82M$121.99M$116.95M-
EPS - Basic$0.87-$0.84$0.76$0.75-$0.75$0.68$0.65-
EPS - Diluted$0.86-$0.83$0.75$0.73-$0.74$0.67$0.64-

Balance Sheet

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Cash & Equivalents$578.08M$853.84M$740.76M$663.26M$561.62M$648.25M$1.02B$914.17M$478.40M$583.67M
Accounts Receivable$1.26B$1.24B$1.28B$1.27B$1.19B$1.20B$1.21B$1.16B$1.15B$1.12B
Inventory----------
Accounts Payable$26.23M$27.53M$34.79M$43.95M$37.28M$36.47M$18.51M$28.43M$28.03M$27.74M
Current Assets$2.41B$2.66B$2.21B$2.14B$1.94B$2.08B$2.40B$2.27B$1.83B$1.89B
Total Assets$5.62B$5.84B$5.36B$5.31B$4.89B$4.99B$5.33B$5.18B$4.74B$4.81B
Current Liabilities$1.43B$1.60B$1.46B$1.39B$791.74M$963.74M$1.29B$1.20B$1.19B$1.32B
Long-term Debt$1.16B$1.17B$827.05M$833.37M$1.19B$1.20B$1.20B$1.21B$818.33M$824.72M
Total Liabilities$3.14B$3.29B$2.82B$2.72B$2.44B$2.60B$2.93B$2.84B$2.44B$2.56B
Stockholders' Equity$2.48B$2.55B$2.54B$2.59B$2.45B$2.39B$2.39B$2.34B$2.30B$2.25B
Retained Earnings$1.44B$1.39B$1.37B$1.35B$1.27B$1.24B$1.21B$1.18B$1.14B$1.09B

Cash Flow

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Operating Cash Flow($23.54M)---$40.44M---($25.56M)-
Investing Cash Flow($31.45M)---$779.0K---($24.67M)-
Financing Cash Flow($204.33M)---($125.54M)---($48.20M)-
CapEx$23.93M---$21.98M---$24.00M-
Free Cash Flow($47.47M)---$18.46M---($49.57M)-

Ratios

MetricQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Profitability
Gross margin36.4%-36.4%35.9%35.3%-35.6%35.4%35.0%-
Operating margin15.3%-14.8%14.3%15.1%-15.0%14.5%14.1%-
EBITDA margin16.7%---16.5%---15.7%-
Net margin11.4%-11.3%10.6%10.8%-11.0%10.4%10.3%-
Free cash flow margin-3.7%---1.5%----4.4%-
FCF / Net income-0.32---0.14----0.42-
R&D / Revenue----------
SG&A / Revenue20.9%-20.3%21.2%19.8%-20.1%20.4%20.8%-
Effective tax rate23.7%-23.0%24.9%25.3%-24.3%24.9%25.2%-
Return on assets2.6%-2.7%2.5%2.7%-2.5%2.4%2.5%-
Return on equity6.0%-5.7%5.1%5.3%-5.5%5.2%5.1%-
Return on invested capital4.2%-4.4%3.9%3.8%-3.8%3.6%3.8%-
Liquidity
Current ratio1.691.661.511.532.452.161.851.891.541.44
Quick ratio1.691.661.511.532.452.161.851.891.541.44
Cash ratio0.410.530.510.480.710.670.790.760.400.44
Leverage
Debt / Equity0.470.460.330.320.480.500.500.520.360.37
Debt / Assets0.210.200.150.160.240.240.230.230.170.17
Debt / EBITDA5.36---5.93---4.62-
Interest coverage----------
Equity multiplier2.272.292.112.052.002.092.222.222.062.14
Liabilities / Assets0.560.560.530.510.500.520.550.550.520.53
Efficiency
Asset turnover0.23-0.240.240.25-0.230.230.24-
Inventory turnover----------
Days sales outstanding355d-362d369d358d-366d360d370d-
Days inventory outstanding----------
Days payable outstanding12d-15d20d17d-9d14d14d-
Cash conversion cycle----------
Valuation
P / E43.3x-50.5x58.7x69.0x-53.0x48.0x51.5x-
P / B2.6x-2.9x3.0x3.7x-2.9x2.5x2.6x-
P / S5.0x-5.7x6.2x7.4x-5.8x5.0x5.3x-
EV / EBITDA32.5x---47.9x---35.7x-
Growth
Revenue growth (YoY)6.7%-6.6%6.6%7.4%-6.6%6.4%3.8%-
Revenue CAGR (3y)6.0%-5.1%4.8%4.4%-6.0%6.0%6.1%-
Revenue CAGR (5y)6.5%-6.7%6.9%5.6%-6.4%5.9%6.9%-
Gross profit growth (YoY)9.9%-8.9%8.1%8.2%-7.1%6.8%7.1%-
Operating income growth (YoY)8.1%-5.5%5.4%14.8%-9.6%8.2%10.3%-
Net income growth (YoY)13.1%-9.8%8.8%11.9%-12.9%4.9%10.2%-
EPS growth (YoY)17.8%-12.2%11.9%14.1%-15.6%6.3%12.3%-
EPS CAGR (3y)14.7%-17.6%25.4%12.7%-11.8%8.1%10.8%-
EPS CAGR (5y)12.8%-14.1%18.6%10.7%-10.5%12.0%15.6%-
FCF growth (YoY)---------6.3%-
FCF CAGR (5y)----------
Book value growth (YoY)0.9%6.7%6.3%10.6%6.7%6.3%19.2%20.9%19.4%23.1%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$5.08B total
High Tech And Manufacturing$2.00B · 39.3%
Consumer And Healthcare$1.72B · 34.0%
Financial Services$1.36B · 26.7%

Product / service

$10.16B total
Core Business Services$3.88B · 38.1%
Digital Operations$2.64B · 26.0%
Data Tech AI$2.44B · 24.0%
Advanced Technology Solutions$1.20B · 11.9%

Geographic

$5.08B total
IN$2.98B · 58.7%
Asia Other Than India$788.06M · 15.5%
Americas$730.43M · 14.4%
Europe$578.39M · 11.4%

Peer comparison

Same SIC group: Services-Management Consulting Services

CompanyRevenue (last FY)Net marginROE
HURN$1.70B6.2%19.9%
BAH$11.22B7.6%77.0%
FCN$3.79B7.1%15.6%
EXPO$582.01M18.2%27.2%
BWMN$490.02M2.6%4.9%

Comparing Genpact LTD against the 5 most active filers in the same SIC group.

Dividends

$0.53/share trailing 12 months · -16.1% YoY

Ex-datePer share
Mar 16, 2026$0.1880
Sep 11, 2025$0.1700
Jun 18, 2025$0.1700
Mar 11, 2025$0.1700
Dec 9, 2024$0.1530
Sep 11, 2024$0.1530
Jun 10, 2024$0.1530
Mar 8, 2024$0.1530
Dec 7, 2023$0.1380
Sep 7, 2023$0.1380
Jun 8, 2023$0.1380
Mar 9, 2023$0.1380
Dec 8, 2022$0.1250
Sep 8, 2022$0.1250
Jun 9, 2022$0.1250
Mar 9, 2022$0.1250
Dec 9, 2021$0.1080
Sep 9, 2021$0.1080
Jun 10, 2021$0.1080
Mar 9, 2021$0.1080
Dec 8, 2020$0.0980
Sep 10, 2020$0.0980
Jun 10, 2020$0.0980
Mar 6, 2020$0.0980